Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine.
about
Immunomodulatory effects of IL-12 released from poly-N-acetyl glucosamine gel matrix during schistosomiasis infectionInterleukin-12: an update on its immunological activities, signaling and regulation of gene expressionCyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C)Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine model.Enhancement of dendritic cells as vaccines for cancerIntratumoral immunotherapy of established solid tumors with chitosan/IL-12.Enhancement of cytotoxic T-lymphocyte response in aged mice by a novel treatment with recombinant AdIL-12 and wild-type adenovirus in rapid succession.Poly-N-acetyl glucosamine gel matrix as a non-viral delivery vector for DNA-based vaccination.Evaluating the role of IL-12 based therapies in ovarian cancer: a review of the literature.Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells.In situ vaccine, immunological memory and cancer cureThe use of growth factors to modulate the activities of antigen-specific CD8+ T cells in vitro.
P2860
Q33849456-C5227382-D601-4AF1-84FA-39AAF8EEEC51Q34248780-75C4AC79-2B6C-4609-9F57-E97726046140Q34732294-CFF478B9-53AB-43E5-94AE-959C832787ECQ34732473-5EF7131B-97E8-4C34-A023-38809A555B2CQ36121187-8E873951-BB77-4789-9068-2D1512FD528DQ36209210-1A462EFE-49BD-49FD-B084-A6FE76D7A989Q36310762-F119D006-0830-4C1D-BE74-36F616C7936AQ36953924-F37F3992-253A-4F53-8428-45C032957014Q37805248-A01C3652-5CF9-4539-973F-83C7082ECF81Q37851520-A2FC7523-5EA3-49D2-8F5D-BEE6F2D0FDB2Q38289899-8CF92D4C-D832-4693-A739-F051C5322B85Q38965014-6F038F56-B03D-4F09-AF54-38353909A51EQ39477666-013FBC48-6672-4B98-B921-96BD3B830794
P2860
Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Paracrine release of IL-12 sti ...... peptide-based cancer vaccine.
@en
type
label
Paracrine release of IL-12 sti ...... peptide-based cancer vaccine.
@en
prefLabel
Paracrine release of IL-12 sti ...... peptide-based cancer vaccine.
@en
P2093
P1476
Paracrine release of IL-12 sti ...... peptide-based cancer vaccine.
@en
P2093
Andre N Kadima
Christophe L Nguyen
David J Cole
John N Vournakis
Marina Demcheva
Mark P Rubinstein
Mohamed L Salem
William E Gillanders
Yuehua Zhou
P304
P356
10.4049/JIMMUNOL.172.9.5159
P407
P577
2004-05-01T00:00:00Z